Trial Profile
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary) ; Zoledronic acid
- Indications Fracture; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms DATA-EX; DATA-HD
- 01 Jan 2021 Status changed from active, no longer recruiting to completed.
- 01 Nov 2019 Results published in the Journal of Clinical Endocrinology and Metabolism
- 14 Mar 2019 Planned End Date changed from 1 Dec 2019 to 1 Jan 2020.